MétaCan
Menu
Back to cohort
Record W2949542758 · doi:10.1002/hon.36_2630

RESULTS OF A MULTICENTER PHASE2 TRIAL OF INVOLVED FIELD RADIOTHERAPY ALONE FOR LOCALIZED NON‐GASTRIC MARGINAL ZONE LYMPHOMA: TROG 05.02

2019· article· en· W2949542758 on OpenAlexaff
Michael MacManus, Daniel Roos, Peter C. O’Brien, Richard Tsang, A. Wirth, Anne Capp, Mathias Bressel, John F. Seymour

Bibliographic record

VenueHematological Oncology · 2019
Typearticle
Languageen
FieldMedicine
TopicLymphoma Diagnosis and Treatment
Canadian institutionsPrincess Margaret Cancer Centre
Fundersnot available
KeywordsMedicineMarginal zone B-cell lymphomaLymphomaSplenic marginal zone lymphomaGastroenterologyInternal medicineRadiation therapyPopulationMantle cell lymphomaStage (stratigraphy)SurgeryMarginal zoneB cellSplenectomySpleenAntibodyImmunology

Abstract

fetched live from OpenAlex

Introduction: We conducted the first prospective phase 2 multicenter clinical trial to assess the long term efficacy and safety of radiotherapy for localized non-gastric marginal zone lymphoma (MZL) and documented the prevalence of autoantibodies, autoimmune events and Helicobacter Pylori (HP) infection in this population. Methods: Eligible patients had untreated stage I or II, or paired-organ confined, non-gastric marginal zone lymphoma. Mandatory investigations included CT and bone marrow aspirate and trephine, autoantibody panel and HP evaluation. FDG-PET was optional. Involved-field or site, conventionally-fractionated radiotherapy was delivered to 30-30.6 Gy, except for orbital MZL which received 24-25 Gy. Results: Six centres enrolled 70 patients. Two patients were ineligible after registration: 68 patients commenced protocol treatment. Median age was 59 (range: 23-84) and 31 (46%) were male. Stage was I n = 55, II n = 9 and IV n = 4. Sites were orbital n = 18, conjunctiva n = 13, lacrimal n = 8, skin n = 8, primary nodal n = 8, salivary n = 7, muscle n = 3 and 15 other extranodal sites with single cases of each. Four patients (6%) had paired organ (salivary or orbital) MZL. Fourteen (21%) were PET-staged. Median follow-up was 5 years (range 0.7 – 9.4). At 7 years, freedom from progression and overall survival were 79% (95% CI: 67-93) (Figure) and 95% (95% CI: 89-100) respectively. One transformation to diffuse large B cell lymphoma occurred. There was one lymphoma-related death and 2 in-field failures (after 25 and 30 Gy respectively). Out-of-field relapse sites were skin (n = 2) duodenum, stomach, paravertebral muscle and conjunctiva. No patient with paired organ disease relapsed. Acute toxicity > grade 3 occurred in 7 cases. Apart from cataracts (n = 18), there were 6 late grade 3 adverse events. Two grade 4 late events (nephrotic syndrome and catheter thrombosis) and two second malignancies were not treatment-related. Autoantibodies or auto-immune events were detected in 26 of 68 (38%) patients. HP infection was detected (and treated) in 15 of 63 patients tested (24%). Neither autoimmunity or HP was detected in 27/68 (40%) patients. Conclusions: Most patients with localized non-gastric MZL had either evidence of autoimmunity or HP infection or both and RT was a highly effective treatment associated with low toxicity and excellent survival.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Randomized trial · Consensus signal: Randomized trial
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.055
Threshold uncertainty score0.673

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0020.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.028
GPT teacher head0.330
Teacher spread0.302 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designRandomized trial
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2019
Admission routes1
Has abstractyes

Explore more

Same venueHematological OncologySame topicLymphoma Diagnosis and TreatmentFrench-language works237,207